In the last trading session, 4.91 million shares of the Elanco Animal Health Incorporated (NYSE:ELAN) were traded. Most recently the company’s share price was $35.53, and it changed around $1.3 or 3.80% from the last close, which brings the market valuation of the company to $16.79B. ELAN currently trades at a discount to its 52-week high of $36.53, offering almost -2.81% off that amount. The share price’s 52-week low was $20.85, which indicates that the current value has risen by an impressive 41.32% since then. We note from Elanco Animal Health Incorporated’s average daily trading volume that its 10-day average is 3.87 million shares, with the 3-month average coming to 3.51 million.
Elanco Animal Health Incorporated stock received a consensus recommendation rating of an Overweight, based on a mean score of 2.20. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 4 recommended ELAN as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight. Elanco Animal Health Incorporated is expected to report earnings per share of $0.26 for the current quarter.
Elanco Animal Health Incorporated (NYSE:ELAN) trade information
Instantly ELAN has showed a green trend with a performance of 3.80% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 35.95 on Tuesday, 07/20/21 increased the stock’s daily price by 1.17%. The company’s shares are currently up 15.85% year-to-date, but still up 3.83% over the last five days. On the other hand, Elanco Animal Health Incorporated (NYSE:ELAN) is 2.42% up in the 30-day period. We can see from the shorts that 8.58 million shares have been sold at a short interest cover period of 2.44 day(s).
The consensus price target as assigned by Wall Street analysts is $38.10, which translates to bulls needing to increase their stock price by 6.75% from its current value. Analyst projections state that ELAN is forecast to be at a low of $29.00 and a high of $42.00. In order for the stock price to hit the forecast high, the stock would need to plunge -18.21% from its current level, while the stock would need to crash 18.38% from its current level to reach the projected low.
Elanco Animal Health Incorporated (ELAN) estimates and forecasts
Elanco Animal Health Incorporated share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 14.02 percent over the past six months and at a 121.28% annual growth rate that is well above the industry average of -5.50%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain 188.90% in revenue this quarter, and will report an increase of 53.80% in the next quarter. The year-over-year growth rate is expected to be 44.00%, up from the previous year.
Consensus estimates provided by 11 financial analysts predict the company will bring in an average of $1.23 billion in revenue for the current quarter. 11 analysts expect Elanco Animal Health Incorporated to make $1.09 billion in revenue for the quarter ending Sep 2021. The company’s sales for the same quarters a year ago were $586.3 million and $889.6 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 110.30%. Forecasts for the next quarter put sales growth at 22.70%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -16.50%. Elanco Animal Health Incorporated earnings are expected to increase by -792.00% in 2021, but the outlook is positive 11.00% per year for the next five years.
Elanco Animal Health Incorporated’s next quarterly earnings report is expected to be released around July 28 and August 02.
Elanco Animal Health Incorporated (NYSE:ELAN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.20% of Elanco Animal Health Incorporated shares, and 101.97% of them are in the hands of institutional investors. The stock currently has a share float of 106.43%. Elanco Animal Health Incorporated stock is held by 638 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Mar 30, 2021, it held 8.91% of the shares, which is about 42.15 million shares worth $1.24 billion.
Price (T.Rowe) Associates Inc, with 8.83% or 41.77 million shares worth $1.23 billion as of Mar 30, 2021, holds the second largest percentage of outstanding shares.
Vanguard/Primecap Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 30, 2021. The former held 14.03 million shares worth $413.13 million, making up 2.97% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 13.29 million shares worth around $391.43 million, which represents about 2.81% of the total shares outstanding.